AROC Stock Analysis: Archrock | NYSE
Oil & Gas Equipment & Services | NYSE, USA | Market Cap: 5.553m USD | 12M Return: 34.4% | US03957W1062 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 57.1M
EPS Trend: 98.6%
Qual. Beats: 0
Rev. Trend: 98.5%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Archrock, Inc. is a US-based energy infrastructure company that operates in two segments. The Contract Operations segment designs, sources, owns, installs, operates, services, and maintains a fleet of natural gas compression equipment under long-term arrangements. The Aftermarket Services segment sells over-the-counter parts and components and provides operations, major and routine maintenance, overhaul, and reconfiguration services for customer-owned compression equipment.
The company serves integrated and independent oil and natural gas processors, gatherers, and transporters. Archrock was founded in 1990, is headquartered in Houston, Texas, and was formerly known as Exterran Holdings, Inc. before adopting its current name in November 2015. It is classified within the GICS Energy sector under the Oil & Gas Equipment & Services sub-industry.
Natural gas compression is a core piece of midstream infrastructure, used to pressurize gas so it can move efficiently through gathering systems, processing facilities, and long-haul pipelines. As a result, demand for compression services is closely tied to US natural gas production volumes and the build-out of gathering and transport networks.
- Natural gas production growth lifts compression horsepower demand
- Aftermarket services margins expand with larger installed fleet base
- Acquisitions and fleet investment scale contract operations capacity
| Net Income: 328.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 6.18 > 1.0 |
| NWC/Revenue: 6.44% < 20% (prev 12.46%; Δ -6.03% < -1%) |
| CFO/TA 0.16 > 3% & CFO 725.6m > Net Income 328.5m |
| Net Debt (2.36b) to EBITDA (805.7m): 2.93 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (174.7m) vs 12m ago -0.30% < -2% |
| Gross Margin: 58.13% > 18% (prev 62.75%; Δ -4.63% > 0.5%) |
| Asset Turnover: 33.91% > 50% (prev 30.44%; Δ 3.47% > 0%) |
| Interest Coverage Ratio: 3.23 > 6 (EBIT TTM 524.1m / Interest Expense TTM 162.4m) |
| A: 0.02 (Total Current Assets 342.8m - Total Current Liabilities 246.0m) / Total Assets 4.44b |
| B: -0.49 (Retained Earnings -2.20b / Total Assets 4.44b) |
| C: 0.12 (EBIT TTM 524.1m / Avg Total Assets 4.44b) |
| D: 0.54 (Book Value of Equity 1.55b / Total Liabilities 2.89b) |
| Altman-Z'' = -0.11 = B |
| DSRI: 1.07 (Receivables 215.5m/179.9m, Revenue 1.50b/1.35b) |
| GMI: 1.08 (GM 62.75% / 58.13%) |
| AQI: 0.96 (AQ_t 0.08 / AQ_t-1 0.09) |
| SGI: 1.12 (Revenue 1.50b / 1.35b) |
| TATA: -0.09 (NI 328.5m - CFO 725.6m) / TA 4.44b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of August 28, 2026, the stock is trading at USD 32.06 with a total of 2,270,241 shares traded. Over the past week, the price has changed by -0.68%, over one month by -9.58%, over three months by -11.27% and over the past year by +34.36%.
Current recommended Stop Loss: 29.50 (which is 8% or 2 ATR below the current price).
Archrock has received a consensus analysts rating of 4.57. Therefore, it is recommended to buy AROC.
- StrongBuy: 4
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 42.5 | 32.6% |
P/E Trailing = 16.4948
P/E Forward = 16.9205
P/S = 3.6909
P/B = 3.4692
P/EG = 1.41
Revenue TTM = 1.50b USD
EBIT TTM = 524.1m USD
EBITDA TTM = 805.7m USD
Long Term Debt = 2.35b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.37b USD (from shortLongTermDebtTotal, last quarter) + Leases 9.40m
Net Debt = 2.36b USD (calculated: Debt 2.37b - CCE 2.00m)
Enterprise Value = 7.92b USD (5.55b + Debt 2.37b - CCE 2.00m)
Interest Coverage Ratio = 3.23 (Ebit TTM 524.1m / Interest Expense TTM 162.4m)
EV/FCF = 27.18x (Enterprise Value 7.92b / FCF TTM 291.3m)
FCF Yield = 3.68% (FCF TTM 291.3m / Enterprise Value 7.92b)
FCF Margin = 19.36% (FCF TTM 291.3m / Revenue TTM 1.50b)
Net Margin = 21.84% (Net Income TTM 328.5m / Revenue TTM 1.50b)
Gross Margin = 58.13% ((Revenue TTM 1.50b - Cost of Revenue TTM 630.0m) / Revenue TTM)
Gross Margin QoQ = 65.86% (prev 47.54%)
Tobins Q-Ratio = 1.78 (Enterprise Value 7.92b / Total Assets 4.44b)
Interest Expense / Debt = 6.86% (Interest Expense 162.4m / Debt 2.37b)
Taxrate = 24.55% (107.0m / 435.7m)
NOPAT = 395.4m (EBIT 524.1m * (1 - 24.55%))
Current Ratio = 1.39 (Total Current Assets 342.8m / Total Current Liabilities 246.0m)
Debt / Equity = 1.52 (Debt 2.37b / totalStockholderEquity, last quarter 1.55b)
Debt / EBITDA = 2.93 (Net Debt 2.36b / EBITDA 805.7m)
Debt / FCF = 8.12 (Net Debt 2.36b / FCF TTM 291.3m)
Total Stockholder Equity = 1.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.40% (Net Income 328.5m / Total Assets 4.44b)
RoE = 21.96% (Net Income TTM 328.5m / Total Stockholder Equity 1.50b)
RoCE = 13.63% (EBIT 524.1m / Capital Employed (Equity 1.50b + L.T.Debt 2.35b))
RoIC = 9.43% (NOPAT 395.4m / Invested Capital 4.19b)
WACC = 7.68% (E(5.55b)/V(7.92b) * Re(8.74%) + D(2.37b)/V(7.92b) * Rd(6.86%) * (1-Tc(0.25)))
Discount Rate = 8.74% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 79.94 | Cagr: 5.62%
[DCF] Terminal Value 77.97% ; FCFF base≈181.5m ; Y1≈208.0m ; Y5≈306.2m
[DCF] Fair Price = 12.79 (EV 4.61b - Net Debt 2.36b = Equity 2.24b / Shares 175.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.59 | EPS CAGR: 55.00% | SUE: -0.72 | # QB: 0
Revenue Correlation: 98.48 | Revenue CAGR: 21.22% | SUE: -3.47 | # QB: -1
EPS current Quarter (2026-09-30): EPS=0.48 | Chg30d=-7.36% | Revisions=-40% | Analysts=4
EPS current Year (2026-12-31): EPS=1.83 | Chg30d=-7.51% | Revisions=-40% | GrowthEPS=-3.7% | GrowthRev=+1.9%
EPS next Year (2027-12-31): EPS=2.19 | Chg30d=-8.75% | Revisions=+0% | GrowthEPS=+19.7% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: -44% (up=1, down=5)